Summary & Overview
HCPCS A4594: Neuromodulation Stimulator Mouthpiece, Adjunct to Rehab Therapy
HCPCS Level II code A4594 identifies a neuromodulation stimulator system mouthpiece supplied as an adjunct to a rehabilitation therapy regimen. Nationally, device-specific HCPCS codes like A4594 matter because they define billable durable medical equipment and supply items that support rehabilitative care pathways and affect coverage determinations across public and private payers. Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will learn what the code represents clinically, the typical service context, and which major payers commonly address coverage for device adjuncts to rehabilitation. The publication outlines standard billing considerations, common modifiers associated with device and supply billing, and how payers may handle coverage determinations for adjunctive neuromodulation devices. It also provides context on typical sites of service and the role of the device within rehabilitation plans. Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code A4594 denotes a neuromodulation stimulator system, adjunct to rehabilitation therapy regime, mouthpiece each. This item is a device component used to deliver neuromodulation as an adjunct to rehabilitative treatment, specifically specified as a mouthpiece. The service type is device supply for neuromodulation adjunctive therapy. The typical site of service for use and fitting is outpatient rehabilitation settings or clinic-based therapy sessions where adjunctive neuromodulation is incorporated into a rehabilitation regimen.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A patient with oropharyngeal dysphagia following a stroke is referred to outpatient rehabilitative services for adjunctive neuromodulation to improve swallowing function. The multidisciplinary team includes a speech-language pathologist and a physiatrist or neurologist who evaluate the patient in a clinic or rehabilitation facility. After baseline instrumental assessment (videofluoroscopic swallow study or fiberoptic endoscopic evaluation of swallowing) documents delayed swallow initiation and reduced laryngeal elevation, the team fits a neuromodulation stimulator mouthpiece device (A4594) as part of a structured rehabilitation regimen. The device is used during supervised therapy sessions to deliver transcutaneous or intraoral stimulation targeting cranial nerve afferents to enhance cortical reorganization. Typical workflow: initial evaluation and consent, device fitting and baseline measurement, scheduled therapy sessions with the mouthpiece adjunct, periodic progress assessments, and documentation of objective swallowing improvements. Typical sites of service are outpatient rehabilitation clinics, hospital-based outpatient therapy departments, and skilled nursing facilities providing rehabilitative therapy.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when services with the device require substantially greater work or complexity than typical. |